Overview of the Current Regulatory Landscape and Challenges in the Development of New Safer and Effective Analgesic Drugs
Panel Session CHAIR: Judy Ashworth, MD, Senior Vice President, Pinney Associates Panelists: Ryan Lanier, Director, Clinical Development & Abuse Liability, Pinney Associates Marc Lesnick, Ph.D., Chief Development Officer, Tris Pharma Jeff Reich, MD, Co-founder & CEO, Sparian Biosciences There is a high unmet medical need to develop new effective analgesics that offer safety advantages over… Read More